{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:45:46Z","timestamp":1787510746784,"version":"build-2736575974"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100017037","name":"Cepheid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017037","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s12325-025-03156-0","type":"journal-article","created":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T03:04:28Z","timestamp":1742699068000},"page":"2385-2402","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Point of Care Nucleic Acid Testing for Influenza-Like Illness: A Cost\u2013Consequence Analysis for High-Risk Patients in Primary Care in Germany"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8065-755X","authenticated-orcid":false,"given":"Johannes","family":"P\u00f6hlmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anika","family":"Joecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Wittki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tray","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9873-7507","authenticated-orcid":false,"given":"Richard F.","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2610-5340","authenticated-orcid":false,"given":"Jordan","family":"Chase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,22]]},"reference":[{"key":"3156_CR1","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2471\/BLT.17.194514","volume":"96","author":"J Fitzner","year":"2018","unstructured":"Fitzner J, Qasmieh S, Mounts AW, et al. Revision of clinical case definitions: influenza-like illness and severe acute respiratory infection. Bull World Health Organ. 2018;96:122\u20138. https:\/\/doi.org\/10.2471\/BLT.17.194514.","journal-title":"Bull World Health Organ"},{"key":"3156_CR2","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.mayocpiqo.2019.12.005","volume":"4","author":"L Dou","year":"2020","unstructured":"Dou L, Reynolds D, Wallace L, et al. Decreased hospital length of stay with early administration of oseltamivir in patients hospitalized with influenza. Mayo Clin Proc Innov Qual Outcomes. 2020;4:176\u201382. https:\/\/doi.org\/10.1016\/j.mayocpiqo.2019.12.005.","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"3156_CR3","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/infdis\/jiw033","volume":"214","author":"IK Oboho","year":"2016","unstructured":"Oboho IK, Reed C, Gargiullo P, et al. Benefit of early initiation of influenza antiviral treatment to pregnant women hospitalized with laboratory-confirmed influenza. J Infect Dis. 2016;214:507\u201315. https:\/\/doi.org\/10.1093\/infdis\/jiw033.","journal-title":"J Infect Dis"},{"key":"3156_CR4","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1093\/jac\/dkq511","volume":"66","author":"A Rodr\u00edguez","year":"2011","unstructured":"Rodr\u00edguez A, D\u00edaz E, Mart\u00edn-Loeches I, et al. Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A. J Antimicrob Chemother. 2011;66:1140\u20139. https:\/\/doi.org\/10.1093\/jac\/dkq511.","journal-title":"J Antimicrob Chemother"},{"key":"3156_CR5","doi-asserted-by":"publisher","first-page":"8377","DOI":"10.1038\/s41467-023-43706-0","volume":"14","author":"CKH Wong","year":"2023","unstructured":"Wong CKH, Lau JJ, Au ICH, et al. Optimal timing of nirmatrelvir\/ritonavir treatment after COVID-19 symptom onset or diagnosis: target trial emulation. Nat Commun. 2023;14:8377. https:\/\/doi.org\/10.1038\/s41467-023-43706-0.","journal-title":"Nat Commun"},{"key":"3156_CR6","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1093\/infdis\/jiz152","volume":"221","author":"S Venkatesan","year":"2020","unstructured":"Venkatesan S, Myles PR, Bolton KJ, et al. Neuraminidase inhibitors and hospital length of stay: a meta-analysis of individual participant data to determine treatment effectiveness among patients hospitalized with nonfatal 2009 pandemic influenza A(H1N1) virus infection. J Infect Dis. 2020;221:356\u201366. https:\/\/doi.org\/10.1093\/infdis\/jiz152.","journal-title":"J Infect Dis"},{"key":"3156_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/cid\/ciy860","volume":"69","author":"J Katzen","year":"2019","unstructured":"Katzen J, Kohn R, Houk JL, Ison MG. Early oseltamivir after hospital admission is associated with shortened hospitalization: a 5-year analysis of oseltamivir timing and clinical outcomes. Clin Infect Dis. 2019;69:52\u20138. https:\/\/doi.org\/10.1093\/cid\/ciy860.","journal-title":"Clin Infect Dis"},{"key":"3156_CR8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/ped.12526","volume":"57","author":"JK Lim","year":"2015","unstructured":"Lim JK, Kilgore PE, Aiello AE, et al. Impact of time to treatment of oseltamivir on influenza hospitalization cost among Korean children. Pediatr Int. 2015;57:393\u2013400. https:\/\/doi.org\/10.1111\/ped.12526.","journal-title":"Pediatr Int"},{"key":"3156_CR9","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-050417","volume":"148","author":"AP Campbell","year":"2021","unstructured":"Campbell AP, Tokars JI, Reynolds S, et al. Influenza antiviral treatment and length of stay. Pediatrics. 2021;148:e2021050417. https:\/\/doi.org\/10.1542\/peds.2021-050417.","journal-title":"Pediatrics"},{"key":"3156_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae427","author":"MW Tenforde","year":"2024","unstructured":"Tenforde MW, Noah KP, O\u2019Halloran AC, et al. Timing of influenza antiviral therapy and risk of death in adults hospitalized with influenza-associated pneumonia, FluSurv-NET, 2012\u20132019. Clin Infect Dis. 2024. https:\/\/doi.org\/10.1093\/cid\/ciae427.","journal-title":"Clin Infect Dis"},{"key":"3156_CR11","volume-title":"S3-Leitlinie: Empfehlungen zur Therapie von Patienten mit COVID-19","author":"S Kluge","year":"2024","unstructured":"Kluge S, Janssens U, Welte T, et al. S3-Leitlinie: Empfehlungen zur Therapie von Patienten mit COVID-19. Marburg and Berlin and K\u00f6ln: AWMF-Institut f\u00fcr Medizinisches Wissensmanagement and Institut f\u00fcr \u00d6ffentliches Gesundheitswesen; 2024."},{"key":"3156_CR12","unstructured":"European Medicines Agency. Tamiflu. 2023. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/tamiflu. Accessed 18 Jun 2024."},{"key":"3156_CR13","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1080\/13696998.2024.2313391","volume":"27","author":"S Davies","year":"2024","unstructured":"Davies S, Boller E, Chase J, et al. A cost-consequence analysis of the Xpert Xpress CoV-2\/Flu\/RSV plus test strategy for the diagnosis of influenza-like illnesses. J Med Econ. 2024;27:430\u201341. https:\/\/doi.org\/10.1080\/13696998.2024.2313391.","journal-title":"J Med Econ"},{"key":"3156_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2296-12-4","volume":"12","author":"B Michiels","year":"2011","unstructured":"Michiels B, Thomas I, Van Royen P, Coenen S. Clinical prediction rules combining signs, symptoms and epidemiological context to distinguish influenza from influenza-like illnesses in primary care: a cross sectional study. BMC Fam Pract. 2011;12:4. https:\/\/doi.org\/10.1186\/1471-2296-12-4.","journal-title":"BMC Fam Pract"},{"key":"3156_CR15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jcv.2015.08.002","volume":"72","author":"S Lacroix","year":"2015","unstructured":"Lacroix S, Vrignaud B, Avril E, et al. Impact of rapid influenza diagnostic test on physician estimation of viral infection probability in paediatric emergency department during epidemic period. J Clin Virol. 2015;72:141\u20135. https:\/\/doi.org\/10.1016\/j.jcv.2015.08.002.","journal-title":"J Clin Virol"},{"key":"3156_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cmi.2021.09.025","volume":"28","author":"E Gentilotti","year":"2022","unstructured":"Gentilotti E, De Nardo P, Cremonini E, et al. Diagnostic accuracy of point-of-care tests in acute community-acquired lower respiratory tract infections: a systematic review and meta-analysis. Clin Microbiol Infect. 2022;28:13\u201322. https:\/\/doi.org\/10.1016\/j.cmi.2021.09.025.","journal-title":"Clin Microbiol Infect"},{"key":"3156_CR17","doi-asserted-by":"publisher","first-page":"ofac681","DOI":"10.1093\/ofid\/ofac681","volume":"10","author":"MW Tenforde","year":"2023","unstructured":"Tenforde MW, Cummings CN, O\u2019Halloran AC, et al. Influenza antiviral use in patients hospitalized with laboratory-confirmed influenza in the United States, FluSurv-NET, 2015\u20132019. Open Forum Infect Dis. 2023;10:ofac681. https:\/\/doi.org\/10.1093\/ofid\/ofac681.","journal-title":"Open Forum Infect Dis"},{"key":"3156_CR18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/14737159.2023.2260743","volume":"24","author":"JL Rakeman-Cagno","year":"2024","unstructured":"Rakeman-Cagno JL, Persing DH, Loeffelholz MJ. Maintaining point of care testing capacity and pandemic preparedness in the post-COVID-19 era. Expert Rev Mol Diagn. 2024;24:147\u201351. https:\/\/doi.org\/10.1080\/14737159.2023.2260743.","journal-title":"Expert Rev Mol Diagn"},{"key":"3156_CR19","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/cid\/ciac013","volume":"75","author":"IV Jani","year":"2022","unstructured":"Jani IV, Peter TF. Nucleic acid point-of-care testing to improve diagnostic preparedness. Clin Infect Dis. 2022;75:723\u20138. https:\/\/doi.org\/10.1093\/cid\/ciac013.","journal-title":"Clin Infect Dis"},{"key":"3156_CR20","unstructured":"Cepheid (2023) Xpert\u00ae Xpress CoV-2\/Flu\/RSV plus: instructions for use. https:\/\/www.cepheid.com\/content\/dam\/www-cepheid-com\/documents\/package-insert-files\/xpert-xpress-cov-2-flu-rsv-plus\/Xpert%20Xpress%20CoV-2%20FLU%20RSV%20plus%20PI%20302-6991%20Rev.%20B%20EUA.pdf. Accessed 12 Aug 2024."},{"key":"3156_CR21","unstructured":"Destatis. Bev\u00f6lkerung: Deutschland, Stichtag [result code: 12411-0001]. 2024. https:\/\/www-genesis.destatis.de\/genesis\/online?sequenz=tabelleErgebnis&&selectionname=12411-0001#abreadcrumb. Accessed 17 Sep 2024."},{"key":"3156_CR22","unstructured":"Verband der Ersatzkassen. Daten zum Gesundheitswesen: Versicherte. In: vdek.com. 2024. https:\/\/www.vdek.com\/presse\/daten\/b_versicherte.html. Accessed 23 Sep 2024."},{"key":"3156_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.25646\/7858.3","volume":"S2","author":"A Rommel","year":"2021","unstructured":"Rommel A, von der Lippe E, Treskova-Schwarzbach M, Scholz S. Bev\u00f6lkerung mit einem erh\u00f6hten Risiko f\u00fcr schwere COVID-19-Verl\u00e4ufe in Deutschland: Auswertungen der Studie GEDA 2019\/2020-EHIS. J Health Monit. 2021;S2:1\u201315. https:\/\/doi.org\/10.25646\/7858.3.","journal-title":"J Health Monit"},{"key":"3156_CR24","unstructured":"Goerlitz L, Tolksdorf K, Prahm K, et al. ARE-Konsultationsinzidenz. 2024. https:\/\/zenodo.org\/records\/13841807. Accessed 2 Oct 2024."},{"key":"3156_CR25","unstructured":"Destatis. Bev\u00f6lkerung: Deutschland, Stichtag, Altersgruppen [result code: 12411-0005]. 2024. https:\/\/www-genesis.destatis.de\/genesis\/online?sequenz=tabelleErgebnis&&selectionname=12411-0005#abreadcrumb. Accessed 17 Sep 2024."},{"key":"3156_CR26","doi-asserted-by":"publisher","DOI":"10.25646\/11985","author":"S Buda","year":"2024","unstructured":"Buda S, D\u00fcrrwald R, Biere B, et al. ARE-Wochenbericht KW 09. ARE-Berichterstattung. 2024. https:\/\/doi.org\/10.25646\/11985.","journal-title":"ARE-Berichterstattung"},{"key":"3156_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.681469","volume":"8","author":"M Dadashi","year":"2021","unstructured":"Dadashi M, Khaleghnejad S, Abedi Elkhichi P, et al. COVID-19 and influenza co-infection: a systematic review and meta-analysis. Front Med. 2021;8:681469. https:\/\/doi.org\/10.3389\/fmed.2021.681469.","journal-title":"Front Med"},{"key":"3156_CR28","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.anpedi.2018.02.011","volume":"90","author":"J Reina","year":"2019","unstructured":"Reina J, Due\u00f1as J. Respiratory co-infections between influenza viruses and respiratory syncytial virus (2014\u20132017). An Pediatr. 2019;90:118\u20139. https:\/\/doi.org\/10.1016\/j.anpedi.2018.02.011.","journal-title":"An Pediatr"},{"key":"3156_CR29","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1001\/jama.2020.6266","volume":"323","author":"D Kim","year":"2020","unstructured":"Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of co-infection between SARS-CoV-2 and other respiratory pathogens. JAMA. 2020;323:2085\u20136. https:\/\/doi.org\/10.1001\/jama.2020.6266.","journal-title":"JAMA"},{"key":"3156_CR30","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/children10010126","volume":"10","author":"A Steponavi\u010dien\u0117","year":"2023","unstructured":"Steponavi\u010dien\u0117 A, Burokien\u0117 S, Iva\u0161kevi\u010dien\u0117 I, et al. Influenza and respiratory syncytial virus infections in pediatric patients during the COVID-19 pandemic: a single-center experience. Children. 2023;10:126. https:\/\/doi.org\/10.3390\/children10010126.","journal-title":"Children"},{"key":"3156_CR31","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1001\/archinte.163.14.1667","volume":"163","author":"L Kaiser","year":"2003","unstructured":"Kaiser L, Wat C, Mills T, et al. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med. 2003;163:1667\u201372. https:\/\/doi.org\/10.1001\/archinte.163.14.1667.","journal-title":"Arch Intern Med"},{"key":"3156_CR32","unstructured":"CDC. Testing for COVID-19. 2024. https:\/\/www.cdc.gov\/covid\/testing\/index.html. Accessed 26 Jul 2024."},{"key":"3156_CR33","unstructured":"Bundeszentrale f\u00fcr gesundheitliche Aufkl\u00e4rung. PCR-test: Goldstandard unter den Corona-Tests. 2023. https:\/\/www.infektionsschutz.de\/coronavirus\/tests-auf-sars-cov-2\/pcr-test\/. Accessed 17 Sep 2024."},{"key":"3156_CR34","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.ajem.2015.03.008","volume":"33","author":"AF Dugas","year":"2015","unstructured":"Dugas AF, Valsamakis A, Atreya MR, et al. Clinical diagnosis of influenza in the emergency department. Am J Emerg Med. 2015;33:770\u20135. https:\/\/doi.org\/10.1016\/j.ajem.2015.03.008.","journal-title":"Am J Emerg Med"},{"key":"3156_CR35","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cmi.2022.10.028","volume":"29","author":"PC Fragkou","year":"2023","unstructured":"Fragkou PC, Moschopoulos CD, Dimopoulou D, et al. Performance of point-of care molecular and antigen-based tests for SARS-CoV-2: a living systematic review and meta-analysis. Clin Microbiol Infect. 2023;29:291\u2013301. https:\/\/doi.org\/10.1016\/j.cmi.2022.10.028.","journal-title":"Clin Microbiol Infect"},{"key":"3156_CR36","doi-asserted-by":"publisher","first-page":"365","DOI":"10.15585\/mmwr.mm7316a2","volume":"73","author":"SE Smith-Jeffcoat","year":"2024","unstructured":"Smith-Jeffcoat SE, Mellis AM, Grijalva CG, et al. SARS-CoV-2 viral shedding and rapid antigen test performance - respiratory virus transmission network, November 2022\u2013May\u00a02023. MMWR Morb Mortal Wkly Rep. 2024;73:365\u201371. https:\/\/doi.org\/10.15585\/mmwr.mm7316a2.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"3156_CR37","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/S1473-3099(21)00146-8","volume":"21","author":"NNY Tsang","year":"2021","unstructured":"Tsang NNY, So HC, Ng KY, et al. Diagnostic performance of different sampling approaches for SARS-CoV-2 RT-PCR testing: a systematic review and meta-analysis. Lancet Infect Dis. 2021;21:1233\u201345. https:\/\/doi.org\/10.1016\/S1473-3099(21)00146-8.","journal-title":"Lancet Infect Dis"},{"key":"3156_CR38","unstructured":"Robert-Koch-Institut. RSV-Infektionen: RKI-Ratgeber. 2024. https:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Merkblaetter\/Ratgeber_RSV.html#doc2394298bodyText10. Accessed 18 Sep 2024."},{"key":"3156_CR39","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3390\/antibiotics10040455","volume":"10","author":"WV Kern","year":"2021","unstructured":"Kern WV, Kostev K. Prevalence of and factors associated with antibiotic prescriptions in patients with acute lower and upper respiratory tract infections-a case-control study. Antibiot Basel Switz. 2021;10:455. https:\/\/doi.org\/10.3390\/antibiotics10040455.","journal-title":"Antibiot Basel Switz"},{"key":"3156_CR40","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1186\/s12879-021-06571-0","volume":"21","author":"R Poss-Doering","year":"2021","unstructured":"Poss-Doering R, Kronsteiner D, Kamradt M, et al. Antibiotic prescribing for acute, non-complicated infections in primary care in Germany: baseline assessment in the cluster randomized trial ARena. BMC Infect Dis. 2021;21:877. https:\/\/doi.org\/10.1186\/s12879-021-06571-0.","journal-title":"BMC Infect Dis"},{"key":"3156_CR41","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1186\/s12889-015-1885-0","volume":"15","author":"B Ehlken","year":"2015","unstructured":"Ehlken B, Anastassopoulou A, Hain J, Schr\u00f6der C, Wahle K. Cost for physician-diagnosed influenza and influenza-like illnesses on primary care level in Germany\u2013results of a database analysis from May\u00a02010 to April 2012. BMC Public Health. 2015;15:578. https:\/\/doi.org\/10.1186\/s12889-015-1885-0.","journal-title":"BMC Public Health"},{"key":"3156_CR42","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1017\/S0950268815002113","volume":"144","author":"G Taylor","year":"2016","unstructured":"Taylor G, Abdesselam K, Pelude L, et al. Epidemiological features of influenza in Canadian adult intensive care unit patients. Epidemiol Infect. 2016;144:741\u201350. https:\/\/doi.org\/10.1017\/S0950268815002113.","journal-title":"Epidemiol Infect"},{"key":"3156_CR43","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1097\/CCM.0b013e3182416f23","volume":"40","author":"TW Rice","year":"2012","unstructured":"Rice TW, Rubinson L, Uyeki TM, et al. Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. Crit Care Med. 2012;40:1487\u201398. https:\/\/doi.org\/10.1097\/CCM.0b013e3182416f23.","journal-title":"Crit Care Med"},{"key":"3156_CR44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.7326\/M22-2141","volume":"176","author":"S Dryden-Peterson","year":"2023","unstructured":"Dryden-Peterson S, Kim A, Kim AY, et al. Nirmatrelvir plus ritonavir for early COVID-19 in a large U.S. health system: a population-based cohort study. Ann Intern Med. 2023;176:77\u201384. https:\/\/doi.org\/10.7326\/M22-2141.","journal-title":"Ann Intern Med"},{"key":"3156_CR45","unstructured":"COVID-NMA initiative. 2022. COVID-NMA: summary of results. https:\/\/covid-nma.com\/summaryofresults\/covidNMA_sof_oct2022.pdf. Accessed 19 Aug 2024."},{"key":"3156_CR46","doi-asserted-by":"publisher","first-page":"5557","DOI":"10.1007\/s12325-021-01887-4","volume":"38","author":"RL Ohsfeldt","year":"2021","unstructured":"Ohsfeldt RL, Choong CK-C, Mc Collam PL, et al. Inpatient hospital costs for COVID-19 patients in the United States. Adv Ther. 2021;38:5557\u201395. https:\/\/doi.org\/10.1007\/s12325-021-01887-4.","journal-title":"Adv Ther"},{"key":"3156_CR47","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/infdis\/jiaa752","volume":"225","author":"JM McLaughlin","year":"2022","unstructured":"McLaughlin JM, Khan F, Schmitt H-J, et al. Respiratory syncytial virus-associated hospitalization rates among US infants: a systematic review and meta-analysis. J Infect Dis. 2022;225:1100\u201311. https:\/\/doi.org\/10.1093\/infdis\/jiaa752.","journal-title":"J Infect Dis"},{"key":"3156_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2023.105399","volume":"161","author":"A Ambrosch","year":"2023","unstructured":"Ambrosch A, Luber D, Klawonn F, Kabesch M. Focusing on severe infections with the respiratory syncytial virus (RSV) in adults: risk factors, symptomatology and clinical course compared to influenza A\/B and the original SARS-CoV-2 strain. J Clin Virol. 2023;161:105399. https:\/\/doi.org\/10.1016\/j.jcv.2023.105399.","journal-title":"J Clin Virol"},{"key":"3156_CR49","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/irv.12912","volume":"16","author":"Y Choi","year":"2022","unstructured":"Choi Y, Hill-Ricciuti A, Branche AR, et al. Cost determinants among adults hospitalized with respiratory syncytial virus in the United States, 2017\u20132019. Influenza Other Respir Viruses. 2022;16:151\u20138. https:\/\/doi.org\/10.1111\/irv.12912.","journal-title":"Influenza Other Respir Viruses"},{"key":"3156_CR50","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12890-017-0552-x","volume":"17","author":"AD Storms","year":"2017","unstructured":"Storms AD, Chen J, Jackson LA, et al. Rates and risk factors associated with hospitalization for pneumonia with ICU admission among adults. BMC Pulm Med. 2017;17:208. https:\/\/doi.org\/10.1186\/s12890-017-0552-x.","journal-title":"BMC Pulm Med"},{"key":"3156_CR51","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.0527","volume":"5","author":"CL Hansen","year":"2022","unstructured":"Hansen CL, Chaves SS, Demont C, Viboud C. Mortality associated with influenza and respiratory syncytial virus in the US, 1999\u20132018. JAMA Netw Open. 2022;5:e220527. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.0527.","journal-title":"JAMA Netw Open"},{"key":"3156_CR52","unstructured":"Centers for Disease Control and Prevention. Deaths. CDC Wonder. 2024. https:\/\/wonder.cdc.gov\/Deaths-by-Underlying-Cause.html. Accessed 18 Sep 2024."},{"key":"3156_CR53","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jinf.2023.01.004","volume":"86","author":"M Reacher","year":"2023","unstructured":"Reacher M, Warne B, Verlander NQ, et al. Oseltamivir is protective for in-patient mortality in PCR confirmed influenza B and influenza A(H3N2) infections in an historic cohort of 1048 patients hospitalised during the 2016\u201317 and 2017\u201318 influenza seasons. J Infect. 2023;86:256\u2013308. https:\/\/doi.org\/10.1016\/j.jinf.2023.01.004.","journal-title":"J Infect"},{"key":"3156_CR54","unstructured":"Destatis. Gesamtindex und 12 Abteilungen. Verbraucherpreisindizes. 2024. https:\/\/www.destatis.de\/DE\/Themen\/Wirtschaft\/Preise\/Verbraucherpreisindex\/Tabellen\/Verbraucherpreise-12Kategorien.html. Accessed 18 Sep 2024."},{"key":"3156_CR55","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41533-022-00325-4","volume":"33","author":"M Brachmann","year":"2023","unstructured":"Brachmann M, Serwa P, Sauerland D. Cost-of-illness comparison between clinical judgment and molecular point-of-care testing for influenza-like illness patients in Germany. NPJ Prim Care Respir Med. 2023;33:3. https:\/\/doi.org\/10.1038\/s41533-022-00325-4.","journal-title":"NPJ Prim Care Respir Med"},{"key":"3156_CR56","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-023-02122-8","author":"P Niekler","year":"2023","unstructured":"Niekler P, Goettler D, Liese JG, Streng A. Hospitalizations due to respiratory syncytial virus (RSV) infections in Germany: a nationwide clinical and direct cost data analysis (2010\u20132019). Infection. 2023. https:\/\/doi.org\/10.1007\/s15010-023-02122-8.","journal-title":"Infection"},{"key":"3156_CR57","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12889-022-12505-5","volume":"22","author":"D Goettler","year":"2022","unstructured":"Goettler D, Niekler P, Liese JG, Streng A. Epidemiology and direct healthcare costs of influenza-associated hospitalizations: nationwide inpatient data (Germany 2010\u20132019). BMC Public Health. 2022;22:108. https:\/\/doi.org\/10.1186\/s12889-022-12505-5.","journal-title":"BMC Public Health"},{"key":"3156_CR58","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/13696998.2023.2290388","volume":"27","author":"K Joshi","year":"2024","unstructured":"Joshi K, Scholz S, Maschio M, et al. Clinical impact and cost-effectiveness of the updated COVID-19 mRNA autumn 2023 vaccines in Germany. J Med Econ. 2024;27:39\u201350. https:\/\/doi.org\/10.1080\/13696998.2023.2290388.","journal-title":"J Med Econ"},{"key":"3156_CR59","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268822001182","volume":"150","author":"A Deb","year":"2022","unstructured":"Deb A, Podmore B, Barnett R, et al. Clinical and economic burden of pneumococcal disease among individuals aged 16\u00a0years and older in Germany. Epidemiol Infect. 2022;150:e204. https:\/\/doi.org\/10.1017\/S0950268822001182.","journal-title":"Epidemiol Infect"},{"key":"3156_CR60","doi-asserted-by":"publisher","DOI":"10.25646\/11862","author":"S Buda","year":"2023","unstructured":"Buda S, D\u00fcrrwald R, Biere B, et al. ARE-Wochenbericht KW 50. ARE-Berichterstattung. 2023. https:\/\/doi.org\/10.25646\/11862.","journal-title":"ARE-Berichterstattung"},{"key":"3156_CR61","unstructured":"Robert-Koch-Institut. Diagramme virologische Surveillance: Deutschland (gesamt) - Saison 2023\/2024. 2024. https:\/\/influenza.rki.de\/Diagrams.aspx?agiRegion=0. Accessed 30 Sep 2024."},{"key":"3156_CR62","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.1002\/jmv.26994","volume":"93","author":"J Lee","year":"2021","unstructured":"Lee J, Song J-U. Diagnostic accuracy of the Cepheid Xpert Xpress and the Abbott ID NOW assay for rapid detection of SARS-CoV-2: a systematic review and meta-analysis. J Med Virol. 2021;93:4523\u201331. https:\/\/doi.org\/10.1002\/jmv.26994.","journal-title":"J Med Virol"},{"key":"3156_CR63","doi-asserted-by":"publisher","first-page":"183","DOI":"10.7883\/yoken.JJID.2020.987","volume":"75","author":"Y-L Liu","year":"2022","unstructured":"Liu Y-L, Xie T-A, Lin G-L, et al. Diagnostic accuracy of Xpert Xpress Flu\/RSV for the detection of influenza and respiratory syncytial viruses. Jpn J Infect Dis. 2022;75:183\u201391. https:\/\/doi.org\/10.7883\/yoken.JJID.2020.987.","journal-title":"Jpn J Infect Dis"},{"key":"3156_CR64","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1093\/cid\/civ733","volume":"61","author":"SS Chaves","year":"2015","unstructured":"Chaves SS, P\u00e9rez A, Miller L, et al. Impact of prompt influenza antiviral treatment on extended care needs after influenza hospitalization among community-dwelling older adults. Clin Infect Dis. 2015;61:1807\u201314. https:\/\/doi.org\/10.1093\/cid\/civ733.","journal-title":"Clin Infect Dis"},{"key":"3156_CR65","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/jpids\/pit071","volume":"3","author":"AJ Blaschke","year":"2014","unstructured":"Blaschke AJ, Shapiro DJ, Pavia AT, et al. A national study of the impact of rapid influenza testing on clinical care in the emergency department. J Pediatr Infect Dis Soc. 2014;3:112\u20138. https:\/\/doi.org\/10.1093\/jpids\/pit071.","journal-title":"J Pediatr Infect Dis Soc"},{"key":"3156_CR66","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.jmoldx.2017.01.009","volume":"19","author":"DT Rogan","year":"2017","unstructured":"Rogan DT, Kochar MS, Yang S, Quinn JV. Impact of rapid molecular respiratory virus testing on real-time decision making in a pediatric emergency department. J Mol Diagn. 2017;19:460\u20137. https:\/\/doi.org\/10.1016\/j.jmoldx.2017.01.009.","journal-title":"J Mol Diagn"},{"key":"3156_CR67","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.diagmicrobio.2018.03.013","volume":"91","author":"AI Vecino-Ortiz","year":"2018","unstructured":"Vecino-Ortiz AI, Goldenberg SD, Douthwaite ST, et al. Impact of a multiplex PCR point-of-care test for influenza A\/B and respiratory syncytial virus on an acute pediatric hospital ward. Diagn Microbiol Infect Dis. 2018;91:331\u20135. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2018.03.013.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"3156_CR68","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1093\/cid\/ciad038","volume":"76","author":"BD Stamm","year":"2023","unstructured":"Stamm BD, Tamerius J, Reddy S, et al. The influence of rapid influenza diagnostic testing on clinician decision-making for patients with acute respiratory infection in urgent care. Clin Infect Dis. 2023;76:1942\u20138. https:\/\/doi.org\/10.1093\/cid\/ciad038.","journal-title":"Clin Infect Dis"},{"key":"3156_CR69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0274222","volume":"17","author":"N Yin","year":"2022","unstructured":"Yin N, Van Nuffelen M, Bartiaux M, et al. Clinical impact of the rapid molecular detection of RSV and influenza A and B viruses in the emergency department. PLoS ONE. 2022;17:e0274222. https:\/\/doi.org\/10.1371\/journal.pone.0274222.","journal-title":"PLoS ONE"},{"key":"3156_CR70","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.4269\/ajtmh.15-0269","volume":"93","author":"LG Tillekeratne","year":"2015","unstructured":"Tillekeratne LG, Bodinayake CK, Nagahawatte A, et al. Use of rapid influenza testing to reduce antibiotic prescriptions among outpatients with influenza-like illness in Southern Sri Lanka. Am J Trop Med Hyg. 2015;93:1031\u20137. https:\/\/doi.org\/10.4269\/ajtmh.15-0269.","journal-title":"Am J Trop Med Hyg"},{"key":"3156_CR71","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.ajem.2018.08.005","volume":"37","author":"EM Schechter-Perkins","year":"2019","unstructured":"Schechter-Perkins EM, Mitchell PM, Nelson KP, et al. Point-of-care influenza testing does not significantly shorten time to disposition among patients with an influenza-like illness. Am J Emerg Med. 2019;37:873\u20138. https:\/\/doi.org\/10.1016\/j.ajem.2018.08.005.","journal-title":"Am J Emerg Med"},{"key":"3156_CR72","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S2213-2600(17)30120-0","volume":"5","author":"NJ Brendish","year":"2017","unstructured":"Brendish NJ, Malachira AK, Armstrong L, et al. Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial. Lancet Respir Med. 2017;5:401\u201311. https:\/\/doi.org\/10.1016\/S2213-2600(17)30120-0.","journal-title":"Lancet Respir Med"},{"key":"3156_CR73","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.3390\/diagnostics14111104","volume":"14","author":"R Daniels","year":"2024","unstructured":"Daniels R, Miles E, Button K. Does the addition of point-of-care testing alter antibiotic prescribing decisions when patients present with acute sore throat to primary care? A prospective test of change. Diagn Basel Switz. 2024;14:1104. https:\/\/doi.org\/10.3390\/diagnostics14111104.","journal-title":"Diagn Basel Switz"},{"key":"3156_CR74","doi-asserted-by":"publisher","first-page":"316","DOI":"10.5694\/mja2.50049","volume":"210","author":"N Wabe","year":"2019","unstructured":"Wabe N, Li L, Lindeman R, et al. The impact of rapid molecular diagnostic testing for respiratory viruses on outcomes for emergency department patients. Med J Aust. 2019;210:316\u201320. https:\/\/doi.org\/10.5694\/mja2.50049.","journal-title":"Med J Aust"},{"key":"3156_CR75","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/j.ajic.2021.04.087","volume":"49","author":"M van der Kraan","year":"2021","unstructured":"van der Kraan M, Hobbelink EL, Kalpoe J, et al. Performance- and cost-benefit analysis of an influenza point-of-care test compared to laboratory-based multiplex RT-PCR in the emergency department. Am J Infect Control. 2021;49:1414\u20138. https:\/\/doi.org\/10.1016\/j.ajic.2021.04.087.","journal-title":"Am J Infect Control"},{"key":"3156_CR76","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2018-001291","volume":"4","author":"LG Tillekeratne","year":"2019","unstructured":"Tillekeratne LG, Bodinayake C, Nagahawatte A, et al. Use of clinical algorithms and rapid influenza testing to manage influenza-like illness: a cost-effectiveness analysis in Sri Lanka. BMJ Glob Health. 2019;4:e001291. https:\/\/doi.org\/10.1136\/bmjgh-2018-001291.","journal-title":"BMJ Glob Health"},{"key":"3156_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtbi.2022.111145","volume":"545","author":"JA Spencer","year":"2022","unstructured":"Spencer JA, Shutt DP, Moser SK, et al. Distinguishing viruses responsible for influenza-like illness. J Theor Biol. 2022;545:111145. https:\/\/doi.org\/10.1016\/j.jtbi.2022.111145.","journal-title":"J Theor Biol"},{"key":"3156_CR78","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2165\/00019053-200826020-00004","volume":"26","author":"JE Stahl","year":"2008","unstructured":"Stahl JE. Modelling methods for pharmacoeconomics and health technology assessment: an overview and guide. Pharmacoeconomics. 2008;26:131\u201348. https:\/\/doi.org\/10.2165\/00019053-200826020-00004.","journal-title":"Pharmacoeconomics"},{"key":"3156_CR79","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1080\/17513758.2010.503376","volume":"4","author":"S Bansal","year":"2010","unstructured":"Bansal S, Read J, Pourbohloul B, Meyers LA. The dynamic nature of contact networks in infectious disease epidemiology. J Biol Dyn. 2010;4:478\u201389. https:\/\/doi.org\/10.1080\/17513758.2010.503376.","journal-title":"J Biol Dyn"},{"key":"3156_CR80","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.3201\/eid2909.230494","volume":"29","author":"PK Moonan","year":"2023","unstructured":"Moonan PK, Smith JP, Borah BF, et al. Home-based testing and COVID-19 isolation recommendations, United States. Emerg Infect Dis. 2023;29:1921\u20134. https:\/\/doi.org\/10.3201\/eid2909.230494.","journal-title":"Emerg Infect Dis"},{"key":"3156_CR81","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1001\/jamainternmed.2021.8075","volume":"182","author":"S Woloshin","year":"2022","unstructured":"Woloshin S, Dewitt B, Krishnamurti T, Fischhoff B. Assessing how consumers interpret and act on results from at-home COVID-19 self-test kits: a randomized clinical trial. JAMA Intern Med. 2022;182:332\u201341. https:\/\/doi.org\/10.1001\/jamainternmed.2021.8075.","journal-title":"JAMA Intern Med"},{"key":"3156_CR82","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jhin.2018.11.010","volume":"101","author":"J Youngs","year":"2019","unstructured":"Youngs J, Marshall B, Farragher M, et al. Implementation of influenza point-of-care testing and patient cohorting during a high-incidence season: a retrospective analysis of impact on infection prevention and control and clinical outcomes. J Hosp Infect. 2019;101:276\u201384. https:\/\/doi.org\/10.1016\/j.jhin.2018.11.010.","journal-title":"J Hosp Infect"},{"key":"3156_CR83","doi-asserted-by":"publisher","first-page":"1149247","DOI":"10.3389\/fpubh.2023.1149247","volume":"11","author":"T Sener","year":"2023","unstructured":"Sener T, Haenen W, Smits P, Hans GH. Large-scale real-life implementation of technology-enabled care to maximize hospitals\u2019 medical surge preparedness during future infectious disease outbreaks and winter seasons: a viewpoint. Front Public Health. 2023;11:1149247. https:\/\/doi.org\/10.3389\/fpubh.2023.1149247.","journal-title":"Front Public Health"},{"key":"3156_CR84","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.zefq.2022.09.006","volume":"175","author":"F Wolf","year":"2022","unstructured":"Wolf F, Matthes A, Markwart R, Bleidorn J. Perspectives of physicians and medical assistants on the implementation of NAAT-based point-of-care testing for SARS-CoV-2 in primary care in Germany. Z Evid Fortbild Qual Gesundhwes. 2022;175:43\u20139. https:\/\/doi.org\/10.1016\/j.zefq.2022.09.006.","journal-title":"Z Evid Fortbild Qual Gesundhwes"},{"key":"3156_CR85","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12875-023-02054-0","volume":"24","author":"A Matthes","year":"2023","unstructured":"Matthes A, Wolf F, Schmiemann G, et al. Point-of-care laboratory testing in primary care: utilization, limitations and perspectives of general practitioners in Germany. BMC Prim Care. 2023;24:96. https:\/\/doi.org\/10.1186\/s12875-023-02054-0.","journal-title":"BMC Prim Care"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03156-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03156-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03156-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T02:50:51Z","timestamp":1744858251000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03156-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,22]]},"references-count":85,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["3156"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03156-0","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,22]]},"assertion":[{"value":"6 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Anika Joecker, Tanja Wittki, and Jordan Chase are employees of Cepheid, which manufactures the Xpert\n                      \u00ae\n                      Xpress CoV-2\/Flu\/RSV test. Richard F. Pollock, Tray Brown, and Johannes P\u00f6hlmann are employees of Covalence Research Ltd, which received consultancy fees from Cepheid for the development of the model and the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The present study is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}